Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 238 results for "celgene corporation headquarters"

Celgene Reports Second Quarter 2016 Operating and Financial Re...

] Celgene Corporation (NASDAQ:CELG) reported net product sales of $2,745 million for the second quarter of 2016, a 22 percent increase from the same period in 2015. Net product sales growth includes a 1 percent negative impact from currency ... TMC Net, 1 month ago
[x]  

Celgene and LYSARC Provide Update on the Phase III REMARC Study of REVLIMID® Maintenance Treatment in Patients with Diffuse Large B-Cell Lymphoma Responding to First-Line R-CHOP Therapy

Celgene Corporation (NASDAQ: CELG) and the Lymphoma Study Association (LYSA) today announced that the Lymphoma Academic Research Organisation (LYSARC) reported initial data from a phase III, randomized, double-blind, international clinical study ...
 BioSpace1 month ago Celgene's Revlimid Fails to Extend Survival in Lymphoma Study  BioSpace1 month ago
[x]  

REVLIMID® (Lenalidomide) Approved by the European Commission for the Treatment of Relapsed/Refractory Patients with Mantle Cell Lymphoma

I Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that the European Commission (EC) has approved REVLIMID ® (lenalidomide) for the treatment of adult patients with relapsed or refractory ...
 PipelineReview1 month ago Celgene Release: REVLIMID (Lenalidomide) Approved By The European Commission (EC) For The Treatment Of Relapsed/Refractory Patients With Mantle Cell Lymphoma  BioSpace1 month ago REVLIMID (Lenalidomide) Approved by the European Commission for the Treatment of Relapsed/Refractory Patients with Mantle Cell Lymphoma  FirstWord Pharma1 month ago REVLIMID ® (Lenalidomide) Approved by the European Commission for the Treatment of Relapsed/Refractory Patients with Mantle Cell Lymphoma  Stockwatch1 month ago
[x]  

USCR, CELGZ Are Seasonally Ripe To Go Up In the Next Five Weeks

BUYINS.NET / www.buyins.net is monitoring the Seasonality of U S Concrete Inc. (NASDAQ:USCR), Celgene Corporation (NASDAQ:CELGZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or ...
 TradingCharts.com1 month ago BUYINS.NET: PRO, AWK, TUZ, VGSH, PALL, CELGZ Are Seasonally Ripe To Go Up In the Next Five Weeks  TradingCharts.com3 weeks ago
Share Market Updates

HC Stocks in Top Row: Celgene Corporation (NASDAQ:CELG), Anthem Inc (NYSE:ANTM)

Shares of Celgene Corporation (NASDAQ:CELG ) ended Thursday session in red amid volatile trading. The shares closed down -0.34 points or -0.33 % at $ 101.42 with 5.39 million shares getting traded. Post opening the session at $ 102.95 , the shares ...
 Share Market Updates1 month ago HC Stocks Outlines: Celgene Corporation (NASDAQ:CELG), Biogen Inc (NASDAQ:BIIB)  Share Market Updates1 month ago HC Stocks Indications: Depomed Inc (NASDAQ:DEPO), Celgene Corporation (NASDAQ:CELG)  Share Market Updates1 month ago

Mergers, Unicorns and Vampires

TeslaCity. The thing about the proposed Tesla/SolarCity merger is that it is good corporate governance. I mean, yes, Elon Musk is a co-founder and biggest shareholder and chief executive officer of Tesla, and yes, Elon Musk is the biggest ...
 Bloomberg View3 weeks ago

Celgene backs four NCI Cancer Centers with $50M to create research consortium

The Abramson Cancer Center at the University of Pennsylvania, The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and The Tisch Cancer Institute at the ...
 Global Hospital & Healthcare Management1 month ago Celgene Inks $50 Million R&D Deal with Four Major Academic Institutions  BioSpace2 months ago Four NCI Cancer Centers Announce Landmark Research Consortium and Collaborations with Celgene  Business Wire2 months ago 4 NCI Cancer Centers announce landmark research consortium and collaborations with Celgene  EurekAlert!2 months ago
[x]  

Biotechnology Equities Under the Scanner - Exelixis, Novavax, Celgene, and Ariad Pharma

NEW YORK , July 7, 2016 /PRNewswire/ -- On Wednesday, July 06, 2016 , the NASDAQ Composite ended the trading session at 4,859.16, up 0.75%; the Dow Jones Industrial Average edged 0.44% higher, to finish at 17,918.62; and the S&P 500 closed at ...
 WorldNetDaily1 month ago Ariad Pharmaceuticals : Biotechnology Equities Under the Scanner - Exelixis, Novavax, Celgene, and Ariad Pharma  4 Traders1 month ago
[x]  

Celgene and Jounce Reach $2.5 Billion Deal

Cambridge Startup Jounce Lands $2.5 Billion Deal With Biotech's Best Friend Celgene July 19, 2016 By Mark Terry , BioSpace.com Breaking News Staff Jounce Therapeutics , a private biotech company headquartered in Cambridge, ...
 Pharma Live1 month ago

A Gilead and Bristol-Myers Squibb Merger—Let Us Count the Ways

By Mark Terry , BioSpace.com Breaking News Staff Speculation that Foster City, California-based Gilead Sciences ( GILD ) will or should buy Bristol-Myers Squibb ( BMY ) have been floating around for at least a year. It has emerged again, largely ...
 BioSpace2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - celgene corporation headquarters
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less